Back to VANGUARD GROUP INC VANGUARD GROUP INC

KNSAKNSA
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in KINIKSA PHARMACEUTICALS INTL

As of its last 13F, for Q4 2025, Vanguard Group held 3,112,937 shares of KNSA (Kiniksa Pharmaceuticals International), worth $128.4M. It increased the position by 49,802 shares (+1.6%) from Q3 2025. Vanguard Group held KNSA from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$128.4M

Current Shares

3.1M

Total Value Change

+$46M

Total Shares Change

-185,319

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
3.1M
+1.6%
$128.4M0.0%$41.25
31
2025-Q3
Decreased
3.1M
-2.2%
$118.9M0.0%$38.83
0
2025-Q2
Decreased
3.1M
-6.8%
$86.7M0.0%$27.67
0
2025-Q1
Increased
3.4M
+4.7%
$74.6M0.0%$22.21
31
2024-Q4
Decreased
3.2M
-2.8%
$63.4M0.0%$19.78
0
2024-Q3
First report
3.3M
-
$82.4M0.0%$24.99
0

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used